| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.62B | 19.22B | 15.93B | 15.12B | 13.06B | 9.85B |
| Gross Profit | 5.82B | 8.12B | 7.06B | 6.58B | 3.52B | 977.79M |
| EBITDA | -5.39B | -1.25B | -3.69B | 3.23B | 1.44B | 1.23B |
| Net Income | -7.61B | -3.40B | -5.38B | -280.18M | -2.68B | -3.05B |
Balance Sheet | ||||||
| Total Assets | 14.61B | 17.10B | 23.18B | 21.56B | 21.31B | 29.12B |
| Cash, Cash Equivalents and Short-Term Investments | 6.29B | 5.41B | 10.81B | 10.92B | 11.88B | 15.24B |
| Total Debt | 902.25M | 977.15M | 1.03B | 212.03M | 332.34M | 0.00 |
| Total Liabilities | 7.20B | 10.31B | 13.13B | 6.43B | 4.41B | 3.73B |
| Stockholders Equity | 7.42B | 6.79B | 10.05B | 15.12B | 16.89B | 25.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.40B | -420.94M | -1.18B | -1.84B | -2.07B |
| Operating Cash Flow | 0.00 | -3.94B | 1.13B | 2.24B | 953.69M | 641.94M |
| Investing Cash Flow | 0.00 | -1.58B | -1.07B | -3.72B | -2.92B | -2.35B |
| Financing Cash Flow | 0.00 | -19.04M | -50.88M | -27.14M | -1.32B | -36.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥28.06B | 11.97 | ― | 0.73% | 17.32% | 33.18% | |
80 Outperform | ¥29.62B | 10.77 | ― | 4.36% | 7.11% | 20.03% | |
78 Outperform | ¥34.35B | 10.88 | ― | 3.40% | 8.54% | 20.57% | |
70 Outperform | ¥25.05B | 50.86 | ― | ― | 31.09% | 75.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥27.10B | 19.53 | ― | 2.51% | -1.52% | -31.82% | |
44 Neutral | ¥19.83B | -9.88 | ― | ― | 20.62% | 36.84% |